CASTLE BIOSCIENCES INC (CSTL) News
Filter CSTL News Items
CSTL News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
CSTL News Highlights
- CSTL's 30 day story count now stands at 2.
- Over the past 8 days, the trend for CSTL's stories per day has been choppy and unclear. It has oscillated between 1 and 1.
Latest CSTL News From Around the Web
Below are the latest news stories about CASTLE BIOSCIENCES INC that investors may wish to consider to help them evaluate CSTL as an investment opportunity.
Castle Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)FRIENDSWOOD, Texas, December 20, 2023--Castle Biosciences reports inducement grants under Nasdaq Listing Rule 5635(c)(4). |
How Much Upside is Left in Castle Biosciences, Inc. (CSTL)? Wall Street Analysts Think 67.01%The mean of analysts' price targets for Castle Biosciences, Inc. (CSTL) points to a 67% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock. |
Study Finds Nurse Practitioners and Physician Assistants Would Alter Patient Care Decisions Based on DecisionDx®-Melanoma Test ResultsFRIENDSWOOD, Texas, December 01, 2023--Castle announced the publication of a new study that assessed the viewpoints of NPs/PAs toward the clinical use of DecisionDx®-Melanoma. |
Castle Biosciences Gains 13%, Insider Trades Reap BenefitLast week, Castle Biosciences, Inc. ( NASDAQ:CSTL ) insiders, who had purchased shares in the previous 12 months were... |
Castle Biosciences Announces Multiple Data Presentations at the 2023 American Society for Dermatologic Surgery Annual MeetingFRIENDSWOOD, Texas, November 14, 2023--Castle announced that data spanning its dermatologic portfolio of GEP tests was recently presented at the 2023 ASDS Annual Meeting. |
Castle Biosciences Ranked Among the Top Workplaces in Houston by the Houston Chronicle for the Third Consecutive YearFRIENDSWOOD, Texas, November 13, 2023--Castle Biosciences has been named a Houston Chronicle Top Workplace for the third year in a row. |
Real-World Evidence Confirms IDgenetix®-Guided Medication Management Significantly Improves Response and Remission Rates in Patients with Major Depressive DisorderFRIENDSWOOD, Texas, November 08, 2023--Castle announces data demonstrating the impact of IDgenetix® on medication response/remission rates in patients with major depressive disorder (MDD). |
Castle Biosciences to Present at Upcoming Investor ConferencesFRIENDSWOOD, Texas, November 08, 2023--Castle Biosciences' executive management will present a company overview at three investor conferences later this month. |
Castle Biosciences, Inc. (NASDAQ:CSTL) Q3 2023 Earnings Call TranscriptCastle Biosciences, Inc. (NASDAQ:CSTL) Q3 2023 Earnings Call Transcript November 3, 2023 Operator: Good afternoon and welcome to Castle Biosciences Third Quarter 2023 Conference Call. As a reminder, today’s call is being recorded. We will begin today’s call with opening remarks and introductions, followed by a question-and-answer session. I would like to turn the call […] |
Q3 2023 Castle Biosciences Inc Earnings CallQ3 2023 Castle Biosciences Inc Earnings Call |